Filing Details
- Accession Number:
- 0001140361-18-043319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-19 06:01:31
- Reporting Period:
- 2018-11-16
- Accepted Time:
- 2018-11-19 06:01:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1010086 | Siga Technologies Inc | SIGA | Pharmaceutical Preparations (2834) | 133864870 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1275756 | G Paul Savas | C/O Siga Technologies, Inc. 31 East 62Nd Street New York NY 10065 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Acquisiton | 2018-11-16 | 5,000 | $5.58 | 237,847 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to $5.60, inclusive. The reporting person undertakes to provide to SIGA Technologies, Inc., any security holder of SIGA Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.